Related Experiment Video
Updated: Feb 23, 2026
06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
1.7K
Platelet-Derived Microvesicles: A Potential Therapy for Trauma-Induced Coagulopathy
Ernesto Lopez1, Amit K Srivastava2, Shibani Pati3
1Center for Translational Injury Research (CeTIR), Department of Surgery, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas.
Shock (Augusta, Ga.)
|September 1, 2017
Summary
Trauma-induced coagulopathy (TIC) patients lack effective treatments. Platelet-derived microvesicles (PMVs) show potential as a novel therapy, offering a hypercoagulable role to address bleeding risks.
Area of Science:
- Biomedical Science
- Hematology
- Trauma Research
Background:
- Trauma patients frequently develop trauma-induced coagulopathy (TIC), a bleeding condition with limited treatment options.
- Current treatments like fresh platelet transfusions are often insufficient and have drawbacks.
Purpose of the Study:
- To review existing literature on platelet-derived microvesicles (PMVs).
- To explore the potential of PMVs as an alternative therapeutic strategy for TIC.
Main Methods:
- Literature review of studies on PMVs and their role in coagulation.
- Analysis of research demonstrating the hypercoagulable effects of PMVs.
Main Results:
- PMVs are cellular fragments with a demonstrated hypercoagulable role.
- Existing research links PMVs to thrombosis-related conditions.
Conclusions:
- PMVs present a promising alternative therapy for trauma-induced coagulopathy.
- Further investigation into isolated human PMV transfusions for TIC is warranted.
More Related Videos
Related Concept Videos
01:22Formation of the Platelet Plug
9.9K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
9.9K
01:05Introduction to Hemostasis
15.2K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
15.2K
01:18Structure and Function of Platelets
4.0K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
4.0K
01:09Coagulation
11.1K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
11.1K
01:16Clot Retraction and Fibrinolysis
9.5K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
9.5K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
13.8K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
13.8K